Human Xtensions

Hand-held Robotic Solutions for Minimally Invasive Surgery

Health Tech & Life Sciences
Active
Public Netanya Founded 2012
Total raised
$66.0M
Last: Series D 2019-01
Stage
Public
Founded
2012
Headcount
42
HQ
Netanya
Sector
Health Tech & Life Sciences

About

Human Xtensions is a medical robotics company developing software-driven devices designed to extend the human hand’s reach. The hand-held device acts as a human extension inside the anatomy and helps restore surgeons’ ease and comfort by providing them with proper ergonomic positioning near each patient for increased freedom, flexibility, proximity, and control.

In March 2018, Human Xtensions received an FDA 510(k) clearance for HandX, its smart, electro-mechanically simplified surgical systems that integrate all of the components required for a modular platform. HandX is designed as a lightweight hand-held device that translates the surgeon’s natural hand motions into complex movements inside the patient.

Funding history · 2 rounds · $66.0M total

2019-01
Series D $9.0M
2016-09
Series C $9.0M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Human Xtensions founded and what is its primary focus?
Human Xtensions was founded in January 2012. It is a medical robotics company focused on developing software-driven, hand-held devices for minimally invasive surgery.
What significant regulatory clearance did Human Xtensions receive for its HandX product?
In March 2018, Human Xtensions received FDA 510(k) clearance for its HandX device, a smart, electro-mechanically simplified surgical system.
What was Human Xtensions' most recent funding round prior to its IPO?
Human Xtensions completed a Series D funding round in January 2019, raising $9 million. Lead investor was Psagot Investment House.
When did Human Xtensions go public and on what exchange?
Human Xtensions went public in December 2020 via an IPO on the TASE (Tel Aviv Stock Exchange) under the ticker HUMX.
What was the estimated valuation of Human Xtensions at the time of its IPO?
At the time of its IPO in December 2020, Human Xtensions had an estimated valuation of $160 million.
What was the total amount of capital raised by Human Xtensions before its IPO?
Human Xtensions raised a total of $66 million in funding prior to its IPO.
What is the current employee count for Human Xtensions?
Human Xtensions currently has 42 employees.
What operational change did Human Xtensions make regarding its US activities in April 2023?
In April 2023, Human Xtensions reduced its operations in the US, aiming to save 31% on expenses.
Did Human Xtensions sign any distribution agreements in 2023?
Yes, in June 2023, Human Xtensions signed an exclusive distribution agreement in Mexico valued at approximately 20 million NIS. In October 2023, the company also entered into a distribution agreement with a company in Abu Dhabi.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Machinery & Robotics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

surgerymedical-technologiesminimally-invasivesurgeonsroboticsmedical-devices